BSEM — Biostem Technologies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapContrarian

Annual balance sheet for Biostem Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2017 December 31st	2020 December 31st	2021 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	ARS	ARS	PRESS	PRESS
Standards:	USG	U USG	U USG	—	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.052	0.101	0.34	0.239	22.8
Net Total Accounts Receivable
Net Total Receivables	0.019	0.012	0.3	11.4	106
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.231	0.851	1	12.6	134
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.68	1.35	1.28	1.37	1.97
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	2.39	2.67	2.74	14.6	140
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.1	6.8	6.73	15.3	99.2
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	1.57	8.47	8.3	15.5	99.5
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	0.818	-5.8	-5.57	-0.984	40.9
Total Liabilities & Shareholders' Equity	2.39	2.67	2.74	14.6	140
Total Common Shares Outstanding
Total Preferred Shares Outstanding